Immix Biopharma, Inc.
IMMX
$2.12
$0.020.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.62M | -4.54M | -4.81M | -7.15M | -4.39M |
| Total Depreciation and Amortization | 79.80K | 59.20K | 41.30K | 25.90K | 24.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 532.20K | 868.40K | 705.70K | 733.80K | 624.90K |
| Change in Net Operating Assets | 700.70K | 1.93M | 2.59M | 2.35M | -1.51M |
| Cash from Operations | -5.31M | -1.69M | -1.48M | -4.04M | -5.26M |
| Capital Expenditure | -127.60K | -67.70K | -507.20K | -271.50K | -97.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -127.60K | -67.70K | -507.20K | -271.50K | -97.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.11M | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.11M | -- | 0.00 | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | 44.10K | -8.00K | -25.10K | 23.00K | 8.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | -- | -- |
| Net Change in Cash | -4.28M | -1.76M | -2.01M | -4.28M | -5.34M |